255920

Sigma-Aldrich

1,1′-(Azodicarbonyl)dipiperidine

99%

Synonym(s):
1,1′-Azobis(N,N-pentamethyleneformamide), Azodicarboxylic acid dipiperidide, NSC 356027, SR 4077, ADD
Empirical Formula (Hill Notation):
C12H20N4O2
CAS Number:
Molecular Weight:
252.31
Beilstein/REAXYS Number:
261917
MDL number:
PubChem Substance ID:
NACRES:
NA.22
Pricing and availability is not currently available.

Quality Level

assay

99%

mp

134-136 °C (lit.)

SMILES string

O=C(\N=N\C(=O)N1CCCCC1)N2CCCCC2

InChI

1S/C12H20N4O2/c17-11(15-7-3-1-4-8-15)13-14-12(18)16-9-5-2-6-10-16/h1-10H2/b14-13+

InChI key

OQJBFFCUFALWQL-BUHFOSPRSA-N

Application

Reactant for preparation of:
  • Polyfluoroalkylated tripyrazolylmethane ligands

  • (-)-Hygromycin A via Mitsunobu glycosylation
  • Optically active α,α-disubstituted amino acids via Mitsunobu reaction
  • Aza-β-lactams through 2+2 cycloaddition reactions
  • Glycosyl disulfides
  • Pyridine ether PPAR agonists
  • S-glycosyl amino acid building blocks for combinatorial neoglycopeptide synthesis
  • Histamine H3 receptor antagonists

Reactant for:
  • Mitsunobu inversion reactions
Widely used reagent for the Mitsunobu reaction
Used in a study of the copper-catalyzed addition of aryboronic acids to azodicarboxyl derivatives providing aryl-substituted hydrazides.

Packaging

5, 25 g in poly bottle

Pictograms

Exclamation mark

Signal Word

Warning

Hazard Statements

Precautionary Statements

Target Organs

Respiratory system

Personal Protective Equipment

dust mask type N95 (US),Eyeshields,Gloves

Hazard Codes

Xi

Risk Statement

36/37/38

Safety Statement

26-36

RIDADR

NONH for all modes of transport

WGK Germany

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

M A Baker et al.
Radiation research, 113(2), 346-355 (1988-02-01)
The mechanism of radiosensitization by diazenedicarboxylic acid bis(N),N-piperidide (SR 4077), a less toxic analog of diamide, was studied using Chinese hamster ovary cells. SR 4077 gave an average SER of 1.58 for postirradiation incubations of 0.5, 1.0, or 2.0 h....
E A Bump et al.
International journal of radiation oncology, biology, physics, 12(8), 1533-1535 (1986-08-01)
Several analogs of the glutathione (GSH) oxidizing reagent diamide [diazenedicarboxylic acid bis(N,N'-diethylamide)] were tested as radiosensitizers of aerobic cells. In general, radiosensitization correlates with the rate of reaction with cellular reducing agents and occurs only when the reductive capacity of...
Hiroki Sato et al.
Bioorganic & medicinal chemistry, 10(5), 1595-1610 (2002-03-12)
Structure--activity relationship studies of 1beta-methyl-2-[(3S,5R)-5-(4-aminomethylphenyl)pyrrolidin-3-ylthio]carbapenems, especially those pertaining to the relationship between antibacterial activity and side-chain structure were conducted. These studies suggested that the trans-(3S,5R)-5-phenylpyrrolidin-3-ylthio side-chain and the aminomethyl group at the 4-position of the phenyl ring play a key...
E A Bump et al.
International journal of radiation oncology, biology, physics, 29(2), 249-253 (1994-05-15)
To determine whether biological effects of radiation, such as apoptosis, that differ from classical clonogenic cell killing, can be modified with agents that would not be expected to modify classical clonogenic cell killing. This would expand the range of potential...
Dougherty, J.M.; et al.
Tetrahedron, 61, 6218-6218 (2005)
Articles
One of the most powerful and widely used carboncarbon bond forming reactions in organic synthesis is the Mitsunobu reaction.
Read More

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.